BCI
JAZZ icon

Brinker Capital Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Brinker Capital Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.28M Sell
22,617
-6,105
-21% -$1.07M 0.04% 419
2025
Q4 		$4.88M Sell
28,722
-1,520
-5% -$233K 0.04% 446
2025
Q3 		$3.99M Buy
30,242
+602
+2% +$72.2K 0.03% 510
2025
Q2 		$3.15M Sell
29,640
-1,311
-4% -$142K 0.03% 560
2025
Q1 		$3.84M Buy
30,951
+326
+1% +$42.5K 0.04% 431
2024
Q4 		$3.77M Buy
30,625
+8,235
+37% +$971K 0.04% 412
2024
Q3 		$2.49M Sell
22,390
-1,986
-8% -$218K 0.02% 581
2024
Q2 		$2.6M Buy
24,376
+3,480
+17% +$383K 0.03% 526
2024
Q1 		$2.52M Buy
20,896
+688
+3% +$84.3K 0.03% 551
2023
Q4 		$2.54M Sell
20,208
-3,518
-15% -$439K 0.03% 522
2023
Q3 		$3.07M Sell
23,726
-157
-0.7% -$20.9K 0.04% 434
2023
Q2 		$2.96M Sell
23,883
-730
-3% -$98.2K 0.03% 490
2023
Q1 		$3.6M Buy
24,613
+1,064
+5% +$157K 0.04% 354
2022
Q4 		$3.75M Sell
23,549
-34
-0.1% -$4.98K 0.07% 265
2022
Q3 		$3.14M Sell
23,583
-541
-2% -$82.3K 0.07% 289
2022
Q2 		$3.76M Sell
24,124
-1,078
-4% -$166K 0.07% 267
2022
Q1 		$3.92M Buy
25,202
+2,309
+10% +$335K 0.06% 301
2021
Q4 		$2.92M Buy
22,893
+124
+0.5% +$16.3K 0.04% 429
2021
Q3 		$4.04M Hold
22,769
– – 0.06% 322
2021
Q2 		$4.04M Buy
22,769
+10,127
+80% +$1.75M 0.05% 369
2021
Q1 		$2.08M Sell
12,642
-9,742
-44% -$1.6M 0.03% 504
2020
Q4 		$3.69M Buy
22,384
+1,939
+9% +$289K 0.06% 400
2020
Q3 		$2.92M Buy
+20,445
New +$2.53M 0.05% 354

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Brinker Capital Investments's JAZZ Position: Q1 2026 in Review

Brinker Capital Investments reduced its Jazz Pharmaceuticals (JAZZ) stake by 21% in Q1 2026, selling an estimated $1.07M and leaving 22,617 shares worth $4.28M. The position accounts for 0.04% of the portfolio, ranked #419.

Brinker Capital Investments first reported a position in JAZZ in Q3 2020 and has held it in 23 quarters since. The position peaked at $4.88M in Q4 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Brinker Capital Investments held 22,617 shares of Jazz Pharmaceuticals worth $4.28M as of Q1 2026.
  • Brinker Capital Investments sold 6,105 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.07M.
  • Jazz Pharmaceuticals made up 0.04% of Brinker Capital Investments's portfolio in Q1 2026, its #419 holding.
  • Brinker Capital Investments first reported a position in Jazz Pharmaceuticals in Q3 2020 and has held it in 23 quarters since.
  • Brinker Capital Investments's Jazz Pharmaceuticals position peaked at $4.88M in Q4 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.